http://www.newstin.com/us/WATSON_PHARMACEUTICALS Global Social News Platform Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/75566572 Drug developer Watson Pharmaceuticals Inc. spent $230,000 in the second quarter to lobby on generic drug issues, federal reimbursement on prescription drugs and proposals on a system for generic biotech drugs, according... Tue, 26 Aug 2008 20:38:35 GMT http://www.newstin.com/tag/us/75566572 2008-08-26T20:38:35Z http://www.newstin.com/tag/us/75291068 Company Notes Hollywood, FL (July 24)—Azopharma Product Development Group added new equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. Zurich, Switzerland (Aug.... Thu, 21 Aug 2008 04:00:00 GMT http://www.newstin.com/tag/us/75291068 2008-08-21T04:00:00Z http://www.newstin.com/tag/us/70004561 Wednesday July 23, 6:30 am ET MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO - News ) announced today that it has been awarded a preclinical grant by The Michael J. Fox Foundation under the foundation’s... Wed, 23 Jul 2008 10:53:41 GMT http://www.newstin.com/tag/us/70004561 2008-07-23T10:53:41Z http://www.newstin.com/tag/us/70001933 MENLO PARK, Calif.--(BUSINESS WIRE)-- Depomed, Inc. (NASDAQ:DEPO) and Rottapharm|Madaus announced today that the Marketing Authorization (MA) for ProQuin XR has been received from the Medical Products Agency in Sweden.... Wed, 23 Jul 2008 09:34:00 GMT http://www.newstin.com/tag/us/70001933 2008-07-23T09:34:00Z http://www.newstin.com/tag/us/69668755 CORONA, CA--(MARKET WIRE)--Jul 21, 2008 -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the Company intends to release its second quarter 2008 financial results on Wednesday,... Mon, 21 Jul 2008 21:03:05 GMT http://www.newstin.com/tag/us/69668755 2008-07-21T21:03:05Z http://www.newstin.com/tag/us/69653819 Monday July 21, 3:16 pm ET Wachovia downgrades 4 generic drugmakers, citing impact of Teva's buyout of Barr WASHINGTON (AP) -- Investment bank Wachovia downgraded four of the largest generic drug companies Monday, indicating it... Mon, 21 Jul 2008 19:22:54 GMT http://www.newstin.com/tag/us/69653819 2008-07-21T19:22:54Z http://www.newstin.com/tag/us/69613647 Filed under: Analyst upgrades and downgrades, Teva Pharm Indus ADR (TEVA)MOST NOTEWORTHY: Stanley Works, the Generic Drug sector, Fiserv and Fidelity National were today's noteworthy downgrades: Deutsche Bank downgraded shares... Mon, 21 Jul 2008 11:11:00 GMT http://www.newstin.com/tag/us/69613647 2008-07-21T11:11:00Z http://www.newstin.com/tag/us/68946339 Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second quarter financial results for 2008 after the market closes on Thursday, July 31, 2008. The company will webcast a conference call beginning at 5:00 p.m.... Thu, 17 Jul 2008 11:00:44 GMT http://www.newstin.com/tag/us/68946339 2008-07-17T11:00:44Z http://www.newstin.com/tag/us/68890167 RNCOS has recently added a new Market Research Report titled, "Booming US Generic Drug Market" to its report gallery. The report does a thorough investigation of both the drivers as well as restraints impacting the market, and... Thu, 17 Jul 2008 09:17:38 GMT http://www.newstin.com/tag/us/68890167 2008-07-17T09:17:38Z http://www.newstin.com/tag/us/67545105 Smith & Nephew appoints Non-Executive Director 10 July 2008 Smith & Nephew plc (LSE: SN, NYSE: SNN ), the global medical technology business, announces the appointment of an additional Non-Executive Director to the Board.... Thu, 10 Jul 2008 09:31:35 GMT http://www.newstin.com/tag/us/67545105 2008-07-10T09:31:35Z